The effect of cytokines and pharmacologic agents on chronic HIV infection - PubMed (original) (raw)

Review

The effect of cytokines and pharmacologic agents on chronic HIV infection

G Poli et al. AIDS Res Hum Retroviruses. 1992 Feb.

Abstract

The ability of the human immunodeficiency virus (HIV) to replicate in CD+ T lymphocytes and mononuclear phagocytes(MP) is strongly influenced by immunoregulatory cytokines. In the T cell system, interleukin-2 (IL-2) provides a mitogenic signal leading to both cell proliferation and virus replication. Among other HIV-inductive cytokines, only tumor necrosis factor-alpha or -beta (TNF-alpha/-beta) have been shown thus far to trigger virus expression both in T cells and MP. The mechanism of action of TNF involves the activation of the cellular transcription factor NF-kB which binds to specific consensus sequences present in the enhancer region of the HIV proviral LTR. In addition, several other cytokines (including colony stimulating factors, IL-1, IL-3, and IL-6) have demonstrated upregulatory effects on HIV production in MP, whereas nonimmune interferons (INF-alpha/-beta) have been shown to suppress HIV replication in T cells and MP by acting at different phases in the virus life cycle. Finally, cytokines such as TGF-beta, IFN-gamma, and IL-4 have demonstrated either upregulatory or suppressive effects on virus expression depending on the experimental conditions. This scenario indicates that HIV expression is under the control of a complex network of immunoregulatory cytokines, in addition to its own endogenous regulatory proteins, suggesting that new pharmacologic strategies may be aimed at either mimicking or interrupting cytokine-dependent virus expression. In this regard, a number of different physiologic and pharmacologic agents capable of interfering with cytokine-mediated events, including glucocorticoids, anti-oxidants, such as N-Acetyl-L-Cysteine (NAC), and retinoic acid (RA) have already been shown to profoundly affect HIV replication in vitro.

PubMed Disclaimer

Cited by

Men with HIV have increased alveolar bone loss.
Skelton M, Callahan C, Levit M, Finn TR, Kister K, Matsumura S, Cantos A, Shah J, Wadhwa S, Yin MT. Skelton M, et al. BMC Oral Health. 2024 Oct 19;24(1):1248. doi: 10.1186/s12903-024-04989-x. BMC Oral Health. 2024. PMID: 39427141 Free PMC article.
CD8+ Lymphocytes from Healthy Blood Donors Secrete Antiviral Levels of Interferon-Alpha.
Teque F, Wegehaupt A, Roufs E, Killian MS. Teque F, et al. Viruses. 2023 Mar 30;15(4):894. doi: 10.3390/v15040894. Viruses. 2023. PMID: 37112874 Free PMC article.
The cytokine/chemokine response in Leishmania/HIV infection and co-infection.
Maksoud S, El Hokayem J. Maksoud S, et al. Heliyon. 2023 Apr 1;9(4):e15055. doi: 10.1016/j.heliyon.2023.e15055. eCollection 2023 Apr. Heliyon. 2023. PMID: 37082641 Free PMC article. Review.
β-Catenin Regulates Wound Healing and IL-6 Expression in Activated Human Astrocytes.
Edara VV, Nooka S, Proulx J, Stacy S, Ghorpade A, Borgmann K. Edara VV, et al. Biomedicines. 2020 Nov 6;8(11):479. doi: 10.3390/biomedicines8110479. Biomedicines. 2020. PMID: 33171974 Free PMC article.
Interleukin-18 in Health and Disease.
Yasuda K, Nakanishi K, Tsutsui H. Yasuda K, et al. Int J Mol Sci. 2019 Feb 2;20(3):649. doi: 10.3390/ijms20030649. Int J Mol Sci. 2019. PMID: 30717382 Free PMC article. Review.

The effect of cytokines and pharmacologic agents on chronic HIV infection - PubMed (original) (raw)